HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Afelimomab-another therapeutic option in sepsis therapy?

AuthorsGuido Grass, Edmund Alwin Martin Neugebauer
JournalCritical care medicine (Crit Care Med) Vol. 32 Issue 11 Pg. 2343-4 (Nov 2004) ISSN: 0090-3493 [Print] United States
PMID15640652 (Publication Type: Editorial, Meta-Analysis, Review, Comment)
Chemical References
  • Antibodies, Monoclonal
  • Interleukin-6
  • afelimomab
Topics
  • Antibodies, Monoclonal (therapeutic use)
  • Critical Care (methods, standards)
  • Evidence-Based Medicine
  • Humans
  • Interleukin-6 (blood)
  • Patient Selection
  • Sepsis (blood, drug therapy, immunology, mortality)
  • Survival Rate
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: